PrEP for people at higher risk of HIV
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study checks whether taking HIV prevention medicine called PrEP can help protect people who are not living with HIV but have recent risk of HIV exposure. You may qualify if you have ongoing risk and are not already taking PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are not infected with HIV (confirmed by a recent rapid or 4th-generation blood test)
- You have used injected drugs at least once in the past month
- You had at least one HIV risk in the past month, such as sharing syringes, trading sex, or having condomless sex with an HIV-positive or unknown-status partner
- You are not currently taking PrEP and have never taken PrEP before
- You can speak and understand English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This study helps make HIV PrEP (a daily pill to prevent HIV) more available through your regular general practitioner, instead of only at specialized clinics. You may qualify if you are at risk for HIV and want to start or restart PrEP.
This trial tests ways to improve how well people take PrEP (a medicine that helps prevent HIV) consistently. It may help you if you’re at higher risk and are not currently on PrEP, especially around starting and staying on it.
This study tests two ways to help men who were assigned male at birth and use methamphetamine stay motivated to start PrEP, a medicine that prevents HIV. You may join if you are HIV-negative or don't know your status and haven't taken PrEP recently.
This study tests a program to help men who recently left prison and use injectable drugs start and stick with PrEP, a daily pill that prevents HIV. It aims to improve health and connect them with care.
This study tests a program to help Black and Hispanic women with substance use disorders take PrEP consistently to prevent HIV. The goal is to see if talking with a health coach can improve PrEP use and reduce HIV risk.
Hear when a new Substance Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.